Gaudium Ivf And Women Health Ltd vs Thyrocare Technologies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Gaudium IVF and Women Health Ltd is ₹ 92.3 as of 23 Oct 15:30 . The P/E Ratio of Gaudium IVF and Women Health Ltd changed from 21.2 on March 2026 to 21.2 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 42.2 on March 2021 to 34.2 on March 2026 . This represents a CAGR of -3.44% over 6 years The Market Cap of Gaudium IVF and Women Health Ltd changed from ₹ 519.04 crore on March 2026 to ₹ 519.04 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 4774 crore on March 2021 to ₹ 5566 crore on March 2026 . This represents a CAGR of 2.59% over 6 years The revenue of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 20.5 crore as compare to the Mar '26 revenue of ₹ 30.53 crore. This represent the decline of -32.85% The revenue of Thyrocare Technologies Ltd for the Jun '26 is ₹ 244.88 crore as compare to the Mar '26 revenue of ₹ 228.84 crore. This represent the growth of 7.01% The ebitda of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 3.55 crore as compare to the Mar '26 ebitda of ₹ 12.35 crore. This represent the decline of -71.26% The ebitda of Thyrocare Technologies Ltd for the Jun '26 is ₹ 82.13 crore as compare to the Mar '26 ebitda of ₹ 79.98 crore. This represent the growth of 2.69% The net profit of Gaudium IVF and Women Health Ltd changed from ₹ 3.4 crore to ₹ 1.78 crore over 7 quarters. This represents a CAGR of -30.91% The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 51.33 crore over 9 quarters. This represents a CAGR of 40.35% The Dividend Payout of Gaudium IVF and Women Health Ltd changed from 47.88 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 149.75 % on March 2026 . This represents a CAGR of 5.22% over 6 years .

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana.
Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center. Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years.
Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited.

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.

FAQs for the comparison of Gaudium IVF and Women Health Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Gaudium IVF and Women Health Ltd or Thyrocare Technologies Ltd?

Market cap of Gaudium IVF and Women Health Ltd is 671 Cr while Market cap of Thyrocare Technologies Ltd is 7,357 Cr

What are the key factors driving the stock performance of Gaudium IVF and Women Health Ltd and Thyrocare Technologies Ltd?

The stock performance of Gaudium IVF and Women Health Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gaudium IVF and Women Health Ltd and Thyrocare Technologies Ltd?

As of October 25, 2026, the Gaudium IVF and Women Health Ltd stock price is INR ₹92.3. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹462.25.

How do dividend payouts of Gaudium IVF and Women Health Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Gaudium IVF and Women Health Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.